logo
Menu

This search function provides links to outputs produced by NIHR Innovation Observatory. These are briefing notes or reports on new or repurposed technologies. This search will not return all technologies currently in development as these outputs are produced as required for our stakeholders.

Innovation Observatory > Reports > Drugs > Human insulin inhalation system (Technosphere Insulin Inhalation System) for type 1 diabetes mellitus

< Back

Human insulin inhalation system (Technosphere Insulin Inhalation System) for type 1 diabetes mellitus

Drugs

Endocrine, Nutritional and Metabolic

September 2010


Human insulin inhalation system (Technosphere Insulin System, Technosphere Insulin) is an insulin inhalation system consisting of dry powder short-acting insulin and a breath- activated inhalation device that delivers the insulin into the respiratory tract. Technosphere Insulin is absorbed more quickly than subcutaneously injected rapid acting insulin analogues and other short-acting human insulin formulations, and has a faster onset and shorter duration of action.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

PDF Report



 

Connect to the Innovation Observatory

Twitter

Load More Related Posts

Get Alerts